Frequent epigenetic silencing of PCDH10 by methylation in human colorectal cancer
Frequent epigenetic silencing of PCDH10 by methylation in human colorectal cancer
复制标题
DOI:
10.1007/s00432-012-1353-5
复制
发表时间:
2013-03
影响因子:
3.6
通讯作者:
Xian Zhong;Yongliang Zhu;Jianshan Mao;Jia-wei Zhang;Shu Zheng
中科院分区:
文献类型:
--
作者:
Xian Zhong;Yongliang Zhu;Jianshan Mao;Jia-wei Zhang;Shu Zheng
PurposeAberrant DNA methylation is common in cancer cells. Epigenetic alterations resulting in the loss of tumor suppression gene functions are frequently involved in tumor development and progression. Recently, methylation ofPCDH10was reported to be associated with multiple hematologic malignancies as well as some solid tumors. Whether the down-regulation ofPCDH10happens in CRC remains unknown.MethodsMethylation status ofPCDH10was evaluated by methylation-specific PCR analysis. The effects ofPCDH10re-expression were determined in growth, colony formation, cell cycle, and invasion assays.ResultsIn this study, we found that 100 % (8 of 8) of colorectal cancer cell lines were silenced forPCDH10, but not normal colorectal epithelial cells. Demethylation treatment confirmed that the reduced expression is associated closely with promoter methylation. Hyper-methylation ofPCDH10was also detected in 85 % of primary colorectal tumors, but not in adjacent normal colorectal tissues.ConclusionsOur results suggest thatPCDH10is an important tumor suppression gene with key roles of suppressing cell proliferation, clonogenicity, and inhibiting cell invasion in the development of colorectal cancer. Thus,PCDH10methylation may constitute a useful biomarker of colorectal cancer patients.